1-8 of 8
Toshinari Takamura
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of Tofogliflozin and Glimepiride Effects on Nonalcoholic Fatty Liver Disease in Participants With Type 2 Diabetes: A Randomized, 48-Week, Open-Label, Active-Controlled Trial

Yumie Takeshita, Masao Honda, Kenichi Harada, Yuki Kita, Noboru Takata, Hiromasa Tsujiguchi, Takeo Tanaka, Hisanori Goto, Yujiro Nakano, Noriho Iida, Kuniaki Arai, Tatsuya Yamashita, Eishiro Mizukoshi, Hiroyuki Nakamura, Shuichi Kaneko, Toshinari Takamura
Journal: Diabetes Care
Diabetes Care 2022;45(9):2064–2075
https://doi.org/10.2337/dc21-2049
Published: 27 July 2022
View article titled, Comparison of Tofogliflozin and Glimepiride Effects on Nonalcoholic Fatty Liver Disease in Participants With Type 2 Diabetes: A Randomized, 48-Week, Open-Label, Active-Controlled Trial
Open the PDF for Comparison of Tofogliflozin and Glimepiride Effects on Nonalcoholic Fatty Liver Disease in Participants With Type 2 Diabetes: A Randomized, 48-Week, Open-Label, Active-Controlled Trial in another window
Journal Articles

Effect of Empagliflozin on Endothelial Function in Patients With Type 2 Diabetes and Cardiovascular Disease: Results from the Multicenter, Randomized, Placebo-Controlled, Double-Blind EMBLEM Trial

Atsushi Tanaka, Michio Shimabukuro, Noritaka Machii, Hiroki Teragawa, Yosuke Okada, Kosuke R. Shima, Toshinari Takamura, Isao Taguchi, Itaru Hisauchi, Shigeru Toyoda, Yasushi Matsuzawa, Hirofumi Tomiyama, Minako Yamaoka-Tojo, Hisako Yoshida, Yasunori Sato, Yumi Ikehara, Shinichiro Ueda, Yukihito Higashi, Koichi Node, EMBLEM Investigators, Junya Ako, Hirohisa Amano, Teruo Inoue, Hideaki Jinnouchi, Atsushi Kawaguchi, Yoshiyuki Kawano, Kazuo Kimura, Akira Kurozumi, Takaaki Kusumoto, Tatsuya Maruhashi, Hirofumi Misu, Katsunori Nakamura, Manabu Narisawa, Junya Nishi, Tsuguhito Ota, Jun-ichi Oyama, Masashi Sakuma, Kazuki Shiina, Seigo Sugiyama, Kunihiro Suzuki, Naohiko Takahashi, Yasuhiko Takemoto, Yumie Takeshita, Hiroshi Tamaki, Akira Tamura, Kenichi Tanaka, Takafumi Toita, Keiichi Torimoto, Hiroki Uehara, Fumi Uemura, Ken Yamakawa, Kunio Yufu
Journal: Diabetes Care
Diabetes Care 2019;42(10):e159–e161
https://doi.org/10.2337/dc19-1177
Published: 12 September 2019
View article titled, Effect of Empagliflozin on Endothelial Function in Patients With Type 2 Diabetes and Cardiovascular Disease: Results from the Multicenter, Randomized, Placebo-Controlled, Double-Blind EMBLEM Trial
Open the PDF for Effect of Empagliflozin on Endothelial Function in Patients With Type 2 Diabetes and Cardiovascular Disease: Results from the Multicenter, Randomized, Placebo-Controlled, Double-Blind EMBLEM Trial in another window
Includes: Supplementary data
Journal Articles

Long-Term Outcomes of Japanese Type 2 Diabetic Patients With Biopsy-Proven Diabetic Nephropathy

Miho Shimizu, MD, Kengo Furuichi, MD, Tadashi Toyama, MD, Shinji Kitajima, MD, Akinori Hara, MD, Kiyoki Kitagawa, MD, Yasunori Iwata, MD, Norihiko Sakai, MD, Toshinari Takamura, MD, Mitsuhiro Yoshimura, MD, Hitoshi Yokoyama, MD, Shuichi Kaneko, MD, Takashi Wada, MD, The Kanazawa Study Group for Renal Diseases and Hypertension
Journal: Diabetes Care
Diabetes Care 2013;36(11):3655–3662
https://doi.org/10.2337/dc13-0298
Published: 15 October 2013
View article titled, Long-Term Outcomes of Japanese Type 2 Diabetic Patients With Biopsy-Proven Diabetic Nephropathy
Open the PDF for Long-Term Outcomes of Japanese Type 2 Diabetic Patients With Biopsy-Proven Diabetic Nephropathy in another window
Includes: Supplementary data
Journal Articles

Histological Course of Nonalcoholic Fatty Liver Disease in Japanese Patients: Tight glycemic control, rather than weight reduction, ameliorates liver fibrosis

Erika Hamaguchi, MD, PHD, Toshinari Takamura, MD, PHD, Masaru Sakurai, MD, PHD, Eishiro Mizukoshi, MD, PHD, Yoh Zen, MD, PHD, Yumie Takeshita, MD, PHD, Seiichiro Kurita, MD, PHD, Kuniaki Arai, MD, PHD, Tatsuya Yamashita, MD, PHD, Motoko Sasaki, MD, PHD, Yasuni Nakanuma, MD, PHD, Shuichi Kaneko, MD, PHD
Journal: Diabetes Care
Diabetes Care 2010;33(2):284–286
https://doi.org/10.2337/dc09-0148
Published: 30 October 2009
View article titled, Histological Course of Nonalcoholic Fatty Liver Disease in Japanese Patients: <subtitle>Tight glycemic control, rather than weight reduction, ameliorates liver fibrosis</subtitle>
Open the PDF for Histological Course of Nonalcoholic Fatty Liver Disease in Japanese Patients: <subtitle>Tight glycemic control, rather than weight reduction, ameliorates liver fibrosis</subtitle> in another window
Includes: Supplementary data
Journal Articles

BMI May Be Better Than Waist Circumference for Defining Metabolic Syndrome in Japanese Women

Masaru Sakurai, MD, PHD, Toshinari Takamura, MD, PHD, Katsuyuki Miura, MD, PHD, Shuichi Kaneko, MD, PHD, Hideaki Nakagawa, MD, PHD
Journal: Diabetes Care
Diabetes Care 2008;31(3):e12
https://doi.org/10.2337/dc07-0309
Published: 01 March 2008
View article titled, BMI May Be Better Than Waist Circumference for Defining Metabolic Syndrome in Japanese Women
Open the PDF for BMI May Be Better Than Waist Circumference for Defining Metabolic Syndrome in Japanese Women in another window
Includes: Supplementary data
Journal Articles

Possible Role of α-Cell Insulin Resistance in Exaggerated Glucagon Responses to Arginine in Type 2 Diabetes

Naomi Tsuchiyama, MD, Toshinari Takamura, MD, PHD, Hitoshi Ando, MD, PHD, Masaru Sakurai, MD, Akiko Shimizu, MD, Ken-ichiro Kato, MD, Seiichiro Kurita, MD, PHD, Shuichi Kaneko, MD, PHD
Journal: Diabetes Care
Diabetes Care 2007;30(10):2583–2587
https://doi.org/10.2337/dc07-0066
Published: 01 October 2007
View article titled, Possible Role of α-Cell Insulin Resistance in Exaggerated Glucagon Responses to Arginine in Type 2 Diabetes
Open the PDF for Possible Role of α-Cell Insulin Resistance in Exaggerated Glucagon Responses to Arginine in Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Predictive Value of Autoantibodies to IA-2 for Insulin Requirements in Japanese Subjects With Type 1 Diabetes

Tsuguhito Ota, MD, PHD, Toshinari Takamura, MD, PHD, Yukihiro Bando, MD, PHD, Rika Usuda, MD, PHD, Yukihiro Nagai, MD, PHD
Journal: Diabetes Care
Diabetes Care 2003;26(11):3188–3189
https://doi.org/10.2337/diacare.26.11.3188
Published: 01 November 2003
View article titled, Predictive Value of Autoantibodies to IA-2 for Insulin Requirements in Japanese Subjects With Type 1 Diabetes
Open the PDF for Predictive Value of Autoantibodies to IA-2 for Insulin Requirements in Japanese Subjects With Type 1 Diabetes in another window
Journal Articles

Preobesity in World Health Organization Classification Involves the Metabolic Syndrome in Japanese

Tsuguhito Ota, MD, Toshinari Takamura, MD, PHD, Nobuyuki Hirai, MD, PHD, Ken-ichi Kobayashi, MD, PHD
Journal: Diabetes Care
Diabetes Care 2002;25(7):1252–1253
https://doi.org/10.2337/diacare.25.7.1252
Published: 01 July 2002
View article titled, Preobesity in World Health Organization Classification Involves the Metabolic Syndrome in Japanese
Open the PDF for Preobesity in World Health Organization Classification Involves the Metabolic Syndrome in Japanese in another window